Latest Mergers And Acquisitions News

Golden Horse Minerals has reported a standout diamond drill intercept of 16m at 6.8 g/t Au with visible gold north of the historic Hopes Hill pit, extending the known mineralised strike to over 2.5km and highlighting the potential for a larger gold system. Follow-up drilling is underway as part of an aggressive 2026 program.

New Murchison Gold (ASX:NMG) has uncovered its deepest and highest-grade gold intercept to date below the Crown Prince open pit, underscoring significant underground mining potential at its flagship Garden Gully project.

DigitalX Limited closed the March 2026 quarter with A$59.5 million in liquid assets, unveiling a A$30 million strategic investment program and delivering record revenue from its Sell My Shares platform, signalling a pivot towards disciplined capital deployment and sustainable growth.

Doctor Care Anywhere posted an 8.4% quarterly jump in consultations and sustained positive cashflow for the fourth consecutive quarter, while launching new digital health initiatives and reaffirming its medium-term revenue and profitability targets.

SQX Resources has wrapped up its maiden 25-hole drilling program at the Red Bird Gold Project in Arizona, revealing a larger, continuous gold system with promising high-grade near-surface mineralisation. The company’s follow-up geophysical work aims to unlock deeper and strike extensions.

Beam Communications (ASX:BCC) reported a modest operating cash inflow of $64K in Q3 FY26, driven by aggressive cost cuts after exiting the Zoleo business. The company’s cash pile surged to $16.4 million following the Zoleo divestment, underpinning a proposed $0.14 per share capital return.

Adelong Gold’s latest drilling at Lauriston validates historic gold grades at Comet and reveals an emerging antimony system at Trojan, signalling potential for a significant gold-antimony corridor in Victoria.

Tolu Minerals has raised AUD 23.75 million through convertible notes from Petrosea, reinforcing its capital position ahead of shareholder approval. The company is also shoring up diesel supplies to safeguard operations at its Tolukuma Gold Mine amid global fuel volatility, while early drilling results hint at further resource potential.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Wellnex Life has pushed back the repayment deadline on nearly $3 million owed to former directors by three months, agreeing to additional fees and interest. Former CEO Zack Bozinovski returns as a consultant, suggesting ongoing strategic recalibration.

XRF Scientific is set to broaden its industrial reach by acquiring Bruker’s Combustion Gas Analysis business for USD 4 million, adding a profitable product line and new market sectors.

Pureprofile delivered a robust Q3 FY26 with 17% revenue growth and a 67% spike in EBITDA, driven by strong international demand and a doubling of platform revenue. The company reaffirmed its FY26 guidance amid ongoing macroeconomic caution.